Log in to save to my catalogue

PSMD14 stabilizes estrogen signaling and facilitates breast cancer progression via deubiquitinating...

PSMD14 stabilizes estrogen signaling and facilitates breast cancer progression via deubiquitinating...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10798890

PSMD14 stabilizes estrogen signaling and facilitates breast cancer progression via deubiquitinating ERα

About this item

Full title

PSMD14 stabilizes estrogen signaling and facilitates breast cancer progression via deubiquitinating ERα

Publisher

London: Nature Publishing Group UK

Journal title

Oncogene, 2024-01, Vol.43 (4), p.248-264

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

The over-activation of ERα signaling is regarded as the major driver for luminal breast cancers, which could be effective controlled via selective estrogen receptor modulators (SERM), such as tamoxifen. The endocrine resistance is still a challenge for breast cancer treatment, while recently studies implicate the post-translational modification on...

Alternative Titles

Full title

PSMD14 stabilizes estrogen signaling and facilitates breast cancer progression via deubiquitinating ERα

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10798890

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10798890

Other Identifiers

ISSN

0950-9232,1476-5594

E-ISSN

1476-5594

DOI

10.1038/s41388-023-02905-1

How to access this item